23 August 2026
The pharmaceutical manufacturing crisis is worsening as procurement policies, rising costs, and imports threaten medicine supply.
22 August 2026
Pharmaceutical localisation talks target pricing reform, investment incentives, medicine security and stronger local manufacturing.
7 August 2026
Local pharmaceutical manufacturing is under pressure as state tenders favour low prices, threatening jobs, medicine supply and investment.
24 May 2026
Explore the latest insights on the SA HIV Treatment Programme, revealing critical changes in treatment enrollment and funding.
13 May 2026
German Drug Price Reforms aim to plug a €40bn health insurance gap by 2030, tightening rebates, reimbursements and hospital funding.
27 April 2026
A new Physicians for Human Rights report warns that recent HIV funding cuts are jeopardising SA's rollout of the lenacapavir injection.
14 April 2026
GLP-1 weight loss medications are gaining traction in South Africa. Discover their potential impact on healthcare and FMCG trends.
11 March 2026
Learn how the new FDA biosimilar development guidance can significantly lower biologic medicine costs and improve accessibility.
7 March 2026
Aspen Pharmacare Debt-Free marks a pivotal moment in its history as it shifts focus toward GLP-1 injectables like semaglutide.
6 March 2026
Join the discussion on local pharmaceutical manufacturing versus cost in South Africa's contentious R15.5bn AIDS drug tender situation.
14 February 2026
9 February 2026
Discover how healthcare investment drives growth, linking public health to stronger GDP performance in emerging markets.